A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 201–300 of 1,002
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
Hansen, H. H., Ægidius, H. M., Oró, D., Evers, S. S., Heebøll, S., Eriksen, P. L., Thomsen, K. L., Bengtsson, A., Veidal, S. S., Feigh, M., et al. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01356-2 · Cited by 156
Bile Acid Signaling in Liver Metabolism and Diseases
Li, T., & Chiang, J. Y. L. (2012) · Journal of Lipids · doi:10.1155/2012/754067 · Cited by 158
“53 μM, respectively, while DCA, CDCA, and CA (in rank order) activate TGR5 at higher 1–8 μM concentrations [56].”
BackgroundCentral anorexigenic actions of bile acids are mediated by TGR5
Perino, A., Velázquez-Villegas, L. A., Bresciani, N., Sun, Y., Huang, Q., Fénelon, V. S., Castellanos-Jankiewicz, A., Zizzari, P., Bruschetta, G., Jin, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00398-4 · Cited by 148
Jiang, Z., Zhuo, L., He, Y., Fu, Y., Shen, L., Xu, F., Gou, W., Miao, Z., Shuai, M., Liang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30712-x · Cited by 168
TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
Perino, A., & Schoonjans, K. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.002 · Cited by 166
Bile acids and the metabolic syndrome
McGlone, E. R., & Bloom, S. R. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218817798 · Cited by 170
“TGR5 is a proto-typical transmembrane G proteincoupled receptor, activation of which leads to intracellular signalling via adenylyl cyclase and cyclic AMP.(67) Depending on the cell line, TGR5 activation may also lead to increase or lowering of intracellular calcium levels.”
Swales, K. E., Korbonits, M., Carpenter, R., Walsh, D. T., Warner, T. D., & Bishop-Bailey, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2399 · Cited by 154
Molecular mechanisms underlying nutrient-stimulated incretin secretion
Parker, H. E., Reimann, F., & Gribble, F. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900132x · Cited by 155
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 154
Bile Acids Regulate Cardiovascular Function
Khurana, S., Raufman, J., & Pallone, T. L. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00272.x · Cited by 151
Gut microbiota-derived metabolites tune host homeostasis fate
Kim, S., Seo, S., & Kweon, M. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01012-x · Cited by 170
“Takeda G protein-coupled receptor 5 (TGR5) is found on cell surfaces and activated by BAs [111].”
BackgroundBile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart
Desai, M. S., Mathur, B., Eblimit, Z., Vasquez, H., Taegtmeyer, H., Karpen, S. J., Penny, D. J., Moore, D. D., & Anakk, S. (2016) · Hepatology · doi:10.1002/hep.28890 · Cited by 160
Kumar, D. P., Asgharpour, A., Mirshahi, F., Park, S. H., Liu, S., Imai, Y., Nadler, J. L., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.699504 · Cited by 143
“In addition to their lipid emulsification properties, bile acids engage a number of receptors such as the farnesoid-x-receptor (FXR) and the takeda Gprotein coupled receptor-5 (TGR5) to mediate their metabolic functions (1-7).”
InfluentialBariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
Chaudhari, S. N., Harris, D. A., Aliakbarian, H., Luo, J. N., Henke, M. T., Subramaniam, R., Vernon, A. H., Tavakkoli, A., Sheu, E. G., & Devlin, A. S. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0604-z · Cited by 160
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
Rieux, A. D., Pourcelle, V., Cani, P. D., Marchand‐Brynaert, J., & Préat, V. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.002 · Cited by 159
Bile acids and bariatric surgery
Albaugh, V. L., Banan, B., Ajouz, H., Abumrad, N. N., & Flynn, C. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.001 · Cited by 148
“TGR5 is not expressed in hepatocytes, but is localized to sinu- soidal endothelial cells (Keitel et al., 2008), monocytes (Kawamata et al., 2003), EECs (Habib et al., 2013; Thomas et al., 2009), adipose tissue (Svensson et al., 2013;Watanabe et al., 2006), smoothmuscle (Rajagopal et al., 2013),…”
BackgroundChenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
Gong, Z., Zhou, J., Zhao, S., Tian, C., Wang, P., Xu, C., Chen, Y., Cai, W., & Wu, J. S. (2016) · Oncotarget · doi:10.18632/oncotarget.13796 · Cited by 155
“Indeed, we observed mature IL-1β release from LPSprimed macrophages in response to CDCA, therefore, one possible explanation for the discrepancy is that we prime macrophages with LPS first and then use CDCA as second signal activating the inflammasome, whereas different strategy was applied in the others studies [39,4…”
ResultYang, Z., Liu, F., Zhu, X., Suo, F., Jia, Z., & Yao, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i24.3609 · Cited by 158
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
Bertolini, A., Fiorotto, R., & Strazzabosco, M. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00935-7 · Cited by 139
Donepudi, A. C., Boehme, S., Li, F., & Chiang, J. Y. L. (2017) · Hepatology · doi:10.1002/hep.28707 · Cited by 147
“Tgr5 is expressed in many tissues, including intestine, gallbladder, liver, and brain.((7-11)) In the liver, Tgr5 is expressed in Kupffer cells and sinusoidal endothelial cells, but not in hepatocytes.”
de Boer, J. F., Verkade, E., Mulder, N. L., de Vries, H. D., Huijkman, N., Koehorst, M., Boer, T., Wolters, J. C., Bloks, V. W., van de Sluis, B., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000243 · Cited by 144
“G-protein-coupled receptor 5 (TGR5; GPBAR1) (5, 6).”
Simonen, M., Dali-Youcef, N., Kaminska, D., Venesmaa, S., Käkelä, P., Pääkkönen, M., Hallikainen, M., Kolehmainen, M., Uusitupa, M., Moilanen, L., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0673-5 · Cited by 145
“More recently, the G-protein family receptor TGR5 has been identified as a cell surface receptor for bile acids [16, 17].”
BackgroundBile acids: a communication channel in the gut-brain axis
Monteiro-Cardoso, V. F., Corlianò, M., & Singaraja, R. R. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08625-z · Cited by 145
Bile Acid-Induced Arrhythmia Is Mediated by Muscarinic M2 Receptors in Neonatal Rat Cardiomyocytes
Sheikh Abdul Kadir, S. H., Miragoli, M., Abu-Hayyeh, S., Moshkov, A. V., Xie, Q., Keitel, V., Nikolaev, V. O., Williamson, C., & Gorelik, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009689 · Cited by 144
“Recently, a bile acid-specific G-protein-coupled receptor TGR5 (also known as GPBAR1, M-BAR and BG37) has been identified[23].”
BackgroundBile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis
Grüner, N., & Mattner, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031397 · Cited by 152
Masyuk, A. I., Huang, B. Q., Radtke, B. N., Gajdos, G. B., Splinter, P. L., Masyuk, T. V., Gradilone, S. A., & LaRusso, N. F. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00383.2012 · Cited by 143
“We found that the effects of TGR5 agonists on ERK1/2 in nonciliated and ciliated cholangiocytes were different and opposite to their effects on cAMP levels.”
BackgroundMethodInfluentialHow bile acids and the microbiota interact to shape host immunity
Lee, M. H., Nuccio, S.-P., Mohanty, I., Hagey, L. R., Dorrestein, P. C., Chu, H., & Raffatellu, M. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01057-x · Cited by 143
“Soon after this, the membrane-bound Takeda-G protein-coupled receptor 5 (TGR5, also known as G-protein-coupled bile acid receptor 1 or BG37) was identified as a cell surface BAR 21,22 .”
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
Fiorucci, S., Cipriani, S., Baldelli, F., & Mencarelli, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.11.001 · Cited by 152
“Bile acids such as taurine-conjugated of lithocholic acid (TLCA), lithocholic acid (LCA), deoxycholic acid (DCA), CDCA and CA induce receptor activation in Gpbar1/Tgr5-expressing HEK293 cells, CHO cells or human NCI-H716 cells in a concentration-dependent manner [6,26].”
BackgroundBile acids: short and long term effects in the intestine
Bajor, A., Gillberg, P.-G., & Abrahamsson, H. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003702734 · Cited by 137
“TGR5 is activated by multipleBAswithdifferentpotency,LCAandTLCAbeing the most potent natural agonists with an EC50 of 530 nM, DCA with intermediate potency and CDCA, CA and UCDA with the lowest potency [108,109].”
BackgroundBile acid receptors in the biliary tree: TGR5 in physiology and disease
Deutschmann, K., Reich, M., Klindt, C., Dröge, C., Spomer, L., Häussinger, D., & Keitel, V. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.021 · Cited by 150
Bile acid receptors in non-alcoholic fatty liver disease
Li, Y., Jadhav, K., & Zhang, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.015 · Cited by 136
“production in THP-1 cell [67], resulting in attenuation of macrophage’s effector functions including reduction of phagocytic activity as well as generation of LPS-stimulated cytokines (TNF-a, IL-1a, IL-1b, IL-6, and IL-8) [66] (Fig.”
BackgroundMetabolism of hydrogen gases and bile acids in the gut microbiome
Hylemon, P. B., Harris, S. C., & Ridlon, J. M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13064 · Cited by 136
Hanafi, N. I., Mohamed, A. S., Kadir, S. H. S. A., & Othman, M. H. D. (2018) · Biomolecules · doi:10.3390/biom8040159 · Cited by 150
“Takeda G-Protein-Coupled Receptor 5 is a type of G-protein-coupled receptors (GPCR) that requires activated G protein leading to cAMP accumulation [35] and signaling kinase proteins,”
Low Affinity GPCRs for Metabolic Intermediates: Challenges for Pharmacologists
Smith, N. J. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00001 · Cited by 135
A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
Han, S., Li, T., Ellis, E., Strom, S., & Chiang, J. Y. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0482 · Cited by 137
Pols, T. W. H., Puchner, T., Korkmaz, H. I., Vos, M., Soeters, M. R., & de Vries, C. J. M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176715 · Cited by 129
Heart and bile acids – Clinical consequences of altered bile acid metabolism
Vasavan, T., Ferraro, E., Ibrahim, E., Dixon, P. H., Gorelik, J., & Williamson, C. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.039 · Cited by 146
“coupled bile acid receptor 1 GPBAR1, mRNA has been identified in moderate levels in human, rabbit and bovine heart tissue, as well as mouse tissue and cardiomyocytes at a protein level [13-15].”
BackgroundBile acid receptors and gastrointestinal functions
Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.001 · Cited by 130
Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
Hov, J. R., Keitel, V., Laerdahl, J. K., Spomer, L., Ellinghaus, E., ElSharawy, A., Melum, E., Boberg, K. M., Manke, T., Balschun, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012403 · Cited by 130
“TGR5 is strongly expressed in monocytes and macrophages, and the receptor has been shown to inhibit the release of inflammatory cytokines from activated macrophages [2,3].”
Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J. (2015) · Microorganisms · doi:10.3390/microorganisms3040641 · Cited by 135
“TGR5 is highly expressed in intestinal tissues and immune cells and is activated by both conjugated as well as unconjugated BAs with highest affinity for secondary BAs (Figure 1) [76,77].”
BackgroundMethodJena, P. K., Sheng, L., Di Lucente, J., Jin, L., Maezawa, I., & Wan, Y. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201700984rr · Cited by 134
“Although FXR is primarily expressed in the liver and gut, where BAs are produced and active, TGR5 is a membrane receptor ubiquitously expressed in endocrine glands, adipocytes, muscles, gut, liver, gall bladder, brain, spinal cord, and the enteric nervous system, as well as immune organs such as the spleen and lymph n…”
BackgroundG-Protein-Coupled Receptor Signaling in Cilia
Mykytyn, K., & Askwith, C. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028183 · Cited by 126
“TGR5 is coupled to Gas and activation of TGR5 by bile acids causes an increase in intracellular cAMP levels (Maruyama et al. 2002; Kawamata et al. 2003).”
BackgroundLavoie, B., Balemba, O. B., Godfrey, C., Watson, C. A., Vassileva, G., Corvera, C. U., Nelson, M. T., & Mawe, G. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.192146 · Cited by 131
“GPBAR1 is known to act via stimulation of the cAMP–PKA pathway (Kawamata et al. 2003).”
BackgroundInfluentialProgress and challenges of selective Farnesoid X Receptor modulation
Massafra, V., Pellicciari, R., Gioiello, A., & van Mil, S. W. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.009 · Cited by 143
Miyazaki-Anzai, S., Masuda, M., Levi, M., Keenan, A. L., & Miyazaki, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108270 · Cited by 123
“Our present study demonstrates that dual activation of FXR and TGR5 strongly alleviates atherosclerotic formation primarily by reducing circulating lipids and reducing inflammation though the inactivation of NF-kB via a protein kinase A-dependent manner.”
BackgroundInfluentialAkkermansia muciniphila protects mice against an emerging tick-borne viral pathogen
Xie, J., Li, H., Zhang, X., Yang, T., Yue, M., Zhang, Y., Chen, S., Cui, N., Yuan, C., Li, J., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01279-6 · Cited by 137
TGR 5 signaling reduces neuroinflammation during hepatic encephalopathy
McMillin, M., Frampton, G., Tobin, R., Dusio, G., Smith, J., Shin, H., Newell‐Rogers, K., Grant, S., & DeMorrow, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13243 · Cited by 126
“To our knowledge, the current study represents the first assessment of TGR5 expression in microglia in the brain, however, monocyte populations from other tissue have been demonstrated to have relatively high expression of this receptor (Kawamata et al. 2003).”
BackgroundMetabolic effects of intestinal absorption and enterohepatic cycling of bile acids
Ferrebee, C. B., & Dawson, P. A. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.001 · Cited by 126
“TGR5 was identi fi ed as a bile acid-activated G-protein coupled receptor in 2003 42 .”
BackgroundKeitel, V., Ullmer, C., & Häussinger, D. (2010) · Biological Chemistry · doi:10.1515/bc.2010.077 · Cited by 129
“TGR5 is coupled to a stimulatory Gprotein and activation of TGR5 by bile acids leads to a rise in intracellular cAMP content (Maruyama et al., 2002; Kawamata et al., 2003).”
Huang, J., Bathena, S. P., Csanaky, I. L., & Alnouti, Y. (2011) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2011.03.035 · Cited by 136
Perspective: TGR5 (Gpbar-1) in liver physiology and disease
Keitel, V., & Häussinger, D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.03.008 · Cited by 131
The Gut–Liver Axis in the Control of Energy Metabolism and Food Intake in Animals
Ringseis, R., Geßner, D. K., & Eder, K. (2019) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083852 · Cited by 134
“In the last two decades, it has become clear that bile acids are not only simple detergents but also potent signaling molecules exhibiting important regulatory effects on metabolic and signaling pathways, at both the intestinal and the systemic level, through binding to different nuclear hormone receptors, including f…”
BackgroundInfluentialThe role of bile acids in cholestatic liver injury
Cai, S.-Y., & Boyer, J. L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5110 · Cited by 120
“TGR5 is characterized as a bile acid receptor because it can be activated by many bile acids, including conjugated and unconjugated forms of lithocholic acid (LCA), deoxycholic acid (DCA), chenodeoxycholic acid (CDCA) and cholic acid, with LCA being the most potent agonist (76,77).”
BackgroundRole of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma
Hong, J., Behar, J., Wands, J., Resnick, M., Wang, L. J., DeLellis, R. A., Lambeth, D., Souza, R. F., Spechler, S. J., & Cao, W. (2010) · Gut · doi:10.1136/gut.2009.188375 · Cited by 123
“[21,30] To test whether this receptor is present in FLO cells, we did RT-PCR.”
MethodZhang, Y.-K. J., Guo, G. L., & Klaassen, C. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016683 · Cited by 122
“lipoprotein synthesis through activating the nuclear receptor, farnesoid X receptor (FXR) [5], and energy expenditure via a membrane receptor, the G-protein-coupled receptor TGR5 [6].”
Perides, G., Laukkarinen, J. M., Vassileva, G., & Steer, M. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.052 · Cited by 123
Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
Langhi, C., Le May, C., Kourimate, S., Caron, S., Staels, B., Krempf, M., Costet, P., & Cariou, B. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.038 · Cited by 113
“In addition, treatment with DCA, a more potent ligand than CDCA for the G protein-coupled cell-surface BA receptor TGR5 [24], moderately increased PCSK9 expression.”
BackgroundInfluentialFXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Carr, R. M., & Reid, A. E. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0500-2 · Cited by 132
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 131
TGR5: A Novel Target for Weight Maintenance and Glucose Metabolism
Chen, X., Lou, G., Meng, Z., & Huang, W. (2011) · Experimental Diabetes Research · doi:10.1155/2011/853501 · Cited by 120
Wu, T., Bound, M. J., Standfield, S. D., Gedulin, B., Jones, K. L., Horowitz, M., & Rayner, C. K. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12043 · Cited by 124
“Bile salts bind to the G-protein-coupled TGR5 receptor present on enteroendocrine L-cells [5], with the potential for stimulation of PYY and GLP-1 secretion [6].”
BackgroundInfluentialRole of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease
Xie, C., Huang, W., Young, R. L., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2021) · Nutrients · doi:10.3390/nu13041104 · Cited by 131
“72 μM [34]/ >10 μM [10] CV-1 cells Reporter gene activation No effect [45]”
BackgroundInfluentialN-Formylated humanin activates both formyl peptide receptor-like 1 and 2
Harada, M., Habata, Y., Hosoya, M., Nishi, K., Fujii, R., Kobayashi, M., & Hinuma, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.046 · Cited by 131
Self-citationDent, P., Fang, Y., Gupta, S., Studer, E., Mitchell, C., Spiegel, S., & Hylemon, P. B. (2005) · Hepatology · doi:10.1002/hep.20942 · Cited by 125
Update on primary sclerosing cholangitis
Karlsen, T. H., & Boberg, K. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.015 · Cited by 122
“Mechanistically, direct evidence so far available on TGR5 on PSC related aspects seems to concern immunosuppressive effects of receptor activation [32–36], more than aspects of bile homeostasis [17,18,37,38].”
BackgroundLithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells
Luu, T. H., Bard, J., Carbonnelle, D., Chaillou, C., Huvelin, J., Bobin‐Dubigeon, C., & Nazih, H. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0353-5 · Cited by 133
“this notion, it has been reported that bile acid binding to TGR5 activates adenylyl cyclase leading to cAMP production and activation of protein kinase A (PKA), which induces further downstream signaling cascades [17, 18].”
BackgroundNon-adrenergic control of lipolysis and thermogenesis in adipose tissues
Braun, K., Oeckl, J., Westermeier, J., Li, Y., & Klingenspor, M. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.165381 · Cited by 117
“In addition to FXR, bile acids signal through another pathway involving the Gs-coupled receptor TGR5 (also GBAR1, M-Bar, BG37) (Fig.”
BackgroundFish protein hydrolysate elevates plasma bile acids and reduces visceral adipose tissue mass in rats
Liaset, B., Madsen, L., Hao, Q., Criales, G., Mellgren, G., Marschall, H., Hallenborg, P., Espe, M., Frøyland, L., & Kristiansen, K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.016 · Cited by 136
“Thus, BA conjugation could also be important for the recently discovered endocrine functions of BAs as systemic bile acids are ligands for the cell surface receptor TGR5 (also called Gpbar1) [18,19].”
BackgroundEndocrine and paracrine role of bile acids
Keitel, V., Kubitz, R., & Häussinger, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5620 · Cited by 122
Tiwari, A., & Maiti, P. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.005 · Cited by 122
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Jiao, T., Ma, Y., Guo, X., Ye, Y., & Xie, C. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00880-z · Cited by 136
“Apart from the classical function as a fat emulsifier, bile acids also function as pivotal signaling molecules involving a series of biological functions such as metabolic homeostasis and immune response through activation of two main bile acid receptors, nuclear FXR and membrane G protein-coupled bile acid receptor 1…”
BackgroundMechanism of action of the bile acid receptor TGR5 in obesity
Lun, W., Yan, Q., Guo, X., Zhou, M., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.011 · Cited by 129
“In the original TGR5 study, Kawamata et al. 45 screened more than 1000 compounds by measuring luciferase activity and detected that BAs [including taurolithocholic acid (TLCA), LCA, DCA, and CDCA] led to increased cAMP in TGR5 gene-transfected cells.”
MethodA Role of the Bile Salt Receptor FXR in Atherosclerosis
Hageman, J., Herrema, H., Groen, A. K., & Kuipers, F. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197897 · Cited by 119
Role of bile acids in inflammatory liver diseases
Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00869-6 · Cited by 121
Reich, M., Spomer, L., Klindt, C., Fuchs, K., Stindt, J., Deutschmann, K., Höhne, J., Liaskou, E., Hov, J. R., Karlsen, T. H., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.03.029 · Cited by 121
Bertaggia, E., Jensen, K. K., Castro-Perez, J., Xu, Y., Di Paolo, G., Chan, R. B., Wang, L., & Haeusler, R. A. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2016 · Cited by 118
“Since the discovery of farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (TGR5) as target receptors for BAs, a wealth of data has shown that BAs act as signaling molecules in various tissues throughout the body, regulating a variety of metabolic pathways (21, 24, 27, 28, 31, 41).”
BackgroundMasse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
“Secondary bile acids, specifically LCA and the taurine conjugate TLCA, are the most potent stimulants of GPBAR1 activation (127, 133, 134).”
BackgroundEffect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets
DiRienzo, D. B. (2014) · Nutrition Reviews · doi:10.1111/nure.12084 · Cited by 119
The Role of FXR in Disorders of Bile Acid Homeostasis
Eloranta, J. J., & Kullak-Ublick, G. A. (2008) · Physiology · doi:10.1152/physiol.00020.2008 · Cited by 119
“Bile acids exert their regulatory effects chiefly by acting as FXR ligands, although they do also elicit other signaling pathways, such as those involving a G-protein-coupled receptor TRG5 (48) and the c-Jun NH2-terminal kinase (JNK) (30), which are likely to contribute to the protection against bile acid-induced dama…”
Hu, M., He, W.-R., Gao, P., Yang, Q., He, K. F., Cao, L.-B., Li, S., Feng, Y., & Shu, H. (2019) · Cell Research · doi:10.1038/s41422-018-0136-1 · Cited by 132
The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation
O’Flaherty, S., Briner Crawley, A., Theriot, C. M., & Barrangou, R. (2018) · mSphere · doi:10.1128/msphere.00140-18 · Cited by 118
“In addition to facilitating adsorption of fats and cholesterol, bile acids can directly shape host physiology in a variety of ways, including acting as signaling molecules for the nuclear receptor farnesoid X receptor (FXR) (5, 6) and the G-proteincoupled TGR5 receptor (7).”
BackgroundCariou, B., Chetiveaux, M., Zaïr, Y., Pouteau, E., Disse, E., Guyomarc'h-Delasalle, B., Laville, M., & Krempf, M. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-48 · Cited by 116
“This metabolic effect of CA is mediated by the binding to the G-protein-coupled receptor TGR5 [11, 12 ], leading to the induction of the cAMP-dependent thyroid hormone activation enzyme DIO2 (type 2 iodothyronine deiodinase) in brown adipose tissue [10].”
BackgroundInfluentialPathophysiological connections between gallstone disease, insulin resistance, and obesity
Cortés, V., Francisco Barrera, M., & Nervi, F. O. (2019) · Obesity Reviews · doi:10.1111/obr.12983 · Cited by 131
Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron
Taketani, M., Zhang, J., Zhang, S., Triassi, A. J., Huang, Y.-J., Griffith, L. G., & Voigt, C. A. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0468-5 · Cited by 124
Ono, E., Inoue, J., Hashidume, T., Shimizu, M., & Sato, R. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.055 · Cited by 129
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 118
Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
Massafra, V., & van Mil, S. W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.003 · Cited by 122
The RAIG Family Member, GPRC5D, Is Associated with Hard-Keratinized Structures
Inoue, S., Nambu, T., & Shimomura, T. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.12628.x · Cited by 114
Bile acids as key modulators of the brain-Gut-Microbiota axis in alzheimer’s disease
Mulak, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210608 · Cited by 114
“The ability to activate two major BA receptors occurs in the following order – for FXR: CDCA > LCA = DCA > CA and for TGR5: LCA > DCA > CDCA > CA [16, 39].”
BackgroundReview article: bile acid diarrhoea – pathogenesis, diagnosis and management
Mottacki, N., Simrén, M., & Bajor, A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13570 · Cited by 110
The Liver at the Nexus of Host-Microbial Interactions
Macpherson, A. J., Heikenwälder, M. F., & Ganal-Vonarburg, S. C. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.016 · Cited by 117
Transport and biological activities of bile acids
Zwicker, B. L., & Agellon, L. B. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.012 · Cited by 130
Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
Watanabe, M., Morimoto, K., Houten, S. M., Kaneko-Iwasaki, N., Sugizaki, T., Horai, Y., Mataki, C., Sato, H., Murahashi, K., Arita, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038286 · Cited by 113
Peroxisomes and bile acid biosynthesis
Ferdinandusse, S., & Houten, S. M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.001 · Cited by 106
“Bile acids have been reported to signal also via alternative pathways, including other NRs, such as the vitamin D receptor (VDR, NR1I1) and constitutive androstane receptor (CAR, NR1I3), and non-NR pathways including mitogen-activated protein kinase (MAPK) pathways [116,117] and the G-proteincoupled receptor (GPCR) TG…”
BackgroundNuclear bile acid signaling through the farnesoid X receptor
Mazuy, C., Helleboid‐Chapman, A., Staels, B., & Lefèbvre, P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1805-y · Cited by 122
“Further studies revealed that BAs are also endogenous ligands for other nuclear receptors (NRs) including pregnane X receptor (PXR) [44], vitamin D receptor (VDR) [45] and the bile acid membrane receptor (TGR5/GPBAR1) [46].”
BackgroundMorville, T., Sahl, R. E., Trammell, S. A. J., Svenningsen, J. S., Gillum, M. P., Helge, J. W., & Clemmensen, C. (2018) · JCI Insight · doi:10.1172/jci.insight.122737 · Cited by 109
Yasuda, H., Hirata, S., Inoue, K., Mashima, H., Ohnishi, H., & Yoshiba, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.168 · Cited by 126
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
Goldberg, A. A., Beach, A., Davies, G. F., Harkness, T. A. A., LeBlanc, A. C., & Titorenko, V. I. (2011) · Oncotarget · doi:10.18632/oncotarget.338 · Cited by 119
“LCA is the most potent natural agonist of TGR5, with EC50 of 530 nM [171,172].”
Nagathihalli, N. S., Beesetty, Y., Lee, W., Washington, M. K., Chen, X., Lockhart, A. C., & Merchant, N. B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2329 · Cited by 112
“TGR5 is a novel G protein-coupled cell surface BA receptor (11).”
BackgroundThe Role of Bile Acids in Chronic Diarrhea
Camilleri, M., & Vijayvargiya, P. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000696 · Cited by 112
“The greatest potency for stimulation of TGR5 is with LCA, followed by DCA, CDCA, and CA (38).”
Background
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.